Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment-Reference-Cited by-同舟云学术

Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment

Published:2022-04 Issue:2 Volume:7 Page:100404
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Conte P.,Ascierto P.A.,Patelli G.,Danesi R.,Vanzulli A.,Sandomenico F.,Tarsia P.,Cattelan A.,Comes A.,De Laurentiis M.,Falcone A.,Regge D.,Richeldi L.,Siena S.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference67 articles.

1. Interstitial lung disease;Antoine,2022

2. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias;Travis;Am J Respir Crit Care Med,2013

3. The role of infection in interstitial lung diseases: a review;Azadeh;Chest,2017

4. Drug-induced interstitial lung disease: a systematic review;Skeoch;J Clin Med,2018

5. Harmonisation in pharmacovigilance;Edwards;Drug Saf,1994

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Near fatal case of mirvetuximab soravtansine-gynx induced interstitial lung disease and a review of the primary literature;Gynecologic Oncology Reports;2024-10

2. Innovative phytoceutical-based drug delivery in the management of pulmonary fibrosis: A roadmap towards inhaled therapeutics;Journal of Drug Delivery Science and Technology;2024-09

3. Oncology-respirology: a discipline in dire need;Trends in Cancer;2024-09

4. Interstitial Pneumonitis Following Sequential Administration of Programmed Death-1/Programmed Death-Ligand1 Inhibitors and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors For Non-Small Cell Lung Cancer: A Matched‐Pair Cohort Study Using a Nationwide Inpatient Database;Clinical Lung Cancer;2024-09

5. A non-enhanced CT-based deep learning diagnostic system for COVID-19 infection at high risk among lung cancer patients;Frontiers in Medicine;2024-08-12